{"id":"https://openalex.org/W298939102","doi":"https://doi.org/10.4137/cmo.s827","title":"A Single Institution's Experience with Bevacizumab in Combination with Cytotoxic Chemotherapy in Progressive Malignant Glioma","display_name":"A Single Institution's Experience with Bevacizumab in Combination with Cytotoxic Chemotherapy in Progressive Malignant Glioma","alternate_titles":[],"publication_year":2008,"publication_date":"2008-01-01","ids":{"openalex":"https://openalex.org/W298939102","doi":"https://doi.org/10.4137/cmo.s827","mag":"298939102","pmid":"https://pubmed.ncbi.nlm.nih.gov/21892317","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3161684"},"language":"en","primary_location":{"id":"doi:10.4137/cmo.s827","doi":"https://doi.org/10.4137/cmo.s827","is_oa":true,"landing_page_url":"https://doi.org/10.4137/cmo.s827","pdf_url":null,"source":{"id":"https://openalex.org/S4210191403","display_name":"Clinical medicine Oncology","issn_l":"1177-9314","issn":["1177-9314"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical medicine. Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W298939102"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.4137/cmo.s827","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074542465","display_name":"Tina M. Mayer","orcid":"https://orcid.org/0000-0003-0078-3773","observed_orcids":["https://orcid.org/0000-0003-0078-3773"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tina Mayer","raw_affiliation_strings":["Medical Oncology, Yale University School of Medicine, New Haven, CT; Yale Medical Oncology, Yale University School of Medicine, New Haven, CT; Neurology, Yale University School of Medicine, New Haven, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Yale University School of Medicine, New Haven, CT; Yale Medical Oncology, Yale University School of Medicine, New Haven, CT; Neurology, Yale University School of Medicine, New Haven, CT","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052643581","display_name":"Jill Lacy","orcid":"https://orcid.org/0000-0002-2297-8435","observed_orcids":["https://orcid.org/0000-0002-2297-8435"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jill Lacy","raw_affiliation_strings":["Medical Oncology, Yale University School of Medicine, New Haven, CT; Yale Medical Oncology, Yale University School of Medicine, New Haven, CT; Neurology, Yale University School of Medicine, New Haven, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Yale University School of Medicine, New Haven, CT; Yale Medical Oncology, Yale University School of Medicine, New Haven, CT; Neurology, Yale University School of Medicine, New Haven, CT","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023990079","display_name":"Joachim M. Baehring","orcid":"https://orcid.org/0000-0001-7755-6793","observed_orcids":["https://orcid.org/0000-0001-7755-6793"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Joachim Baehring","raw_affiliation_strings":["Medical Oncology, Yale University School of Medicine, New Haven, CT; Yale Medical Oncology, Yale University School of Medicine, New Haven, CT; Neurology, Yale University School of Medicine, New Haven, CT","Neurology, Yale University School of Medicine, New Haven, CT","Yale Medical Oncology, Yale University School of Medicine, New Haven, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Yale University School of Medicine, New Haven, CT; Yale Medical Oncology, Yale University School of Medicine, New Haven, CT; Neurology, Yale University School of Medicine, New Haven, CT","institution_ids":["https://openalex.org/I32971472"]},{"raw_affiliation_string":"Neurology, Yale University School of Medicine, New Haven, CT","institution_ids":["https://openalex.org/I32971472"]},{"raw_affiliation_string":"Yale Medical Oncology, Yale University School of Medicine, New Haven, CT","institution_ids":["https://openalex.org/I32971472"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5023990079"],"corresponding_institution_ids":["https://openalex.org/I32971472"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"2","issue":null,"first_page":"455","last_page":"459"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":1.0},{"id":"https://openalex.org/keywords/high-grade-glioma","display_name":"high-grade glioma","score":0.972000002861023},{"id":"https://openalex.org/keywords/irinotecan","display_name":"irinotecan","score":0.9229999780654907},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":0.9900000095367432},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.6420000195503235},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.43799999356269836},{"id":"https://openalex.org/keywords/thromboembolism","display_name":"thromboembolism","score":0.9229999780654907},{"id":"https://openalex.org/keywords/time-to-treatment-failure","display_name":"time to treatment failure","score":0.9110000133514404},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9409999847412109},{"id":"https://openalex.org/keywords/recurrent-glioma","display_name":"recurrent glioma","score":0.6209999918937683}],"concepts":[{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.9723199605941772},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9309102296829224},{"id":"https://openalex.org/C2780259306","wikidata":"https://www.wikidata.org/wiki/Q412197","display_name":"Irinotecan","level":4,"score":0.8031054735183716},{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.6445778012275696},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.616388201713562},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5481652021408081},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5310922861099243},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5102636814117432},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.5097050666809082},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.48758572340011597},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4818800091743469},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.33591780066490173},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2709859609603882},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.0},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.0}],"mesh":[],"locations_count":6,"locations":[{"id":"doi:10.4137/cmo.s827","doi":"https://doi.org/10.4137/cmo.s827","is_oa":true,"landing_page_url":"https://doi.org/10.4137/cmo.s827","pdf_url":null,"source":{"id":"https://openalex.org/S4210191403","display_name":"Clinical medicine Oncology","issn_l":"1177-9314","issn":["1177-9314"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical medicine. Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3161684","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3161684/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3161684/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clin Med Oncol","raw_type":"Text"},{"id":"pmid:21892317","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21892317","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical medicine. Oncology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:bdbc7a08ac6c4a1bbf9602964cad2ce2","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/bdbc7a08ac6c4a1bbf9602964cad2ce2","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Clinical Medicine Insights: Oncology, Vol 2 (2008)","raw_type":"article"},{"id":"pmh:oai:libertasacademica.com/851","doi":null,"is_oa":false,"landing_page_url":"http://insights.sagepub.com/redirect_file.php?fileId=1167&filename=CMO-2-Mayer-et-al&fileType=pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://insights.sagepub.com/a-single-institutions-experience-with-bevacizumab-in-combination-with--article-a851","raw_type":null},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.289.6279","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.289.6279","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/33/23/Clin_Med_Oncol_2008_Jun_9_2_455-459.tar.gz","raw_type":"text"}],"best_oa_location":{"id":"doi:10.4137/cmo.s827","doi":"https://doi.org/10.4137/cmo.s827","is_oa":true,"landing_page_url":"https://doi.org/10.4137/cmo.s827","pdf_url":null,"source":{"id":"https://openalex.org/S4210191403","display_name":"Clinical medicine Oncology","issn_l":"1177-9314","issn":["1177-9314"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical medicine. Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W298939102.pdf","grobid_xml":"https://content.openalex.org/works/W298939102.grobid-xml"},"referenced_works_count":34,"referenced_works":["https://openalex.org/W176577860","https://openalex.org/W179710673","https://openalex.org/W1858161324","https://openalex.org/W1940514332","https://openalex.org/W1970510435","https://openalex.org/W1995369709","https://openalex.org/W2019819723","https://openalex.org/W2049229287","https://openalex.org/W2071752743","https://openalex.org/W2093783077","https://openalex.org/W2094269006","https://openalex.org/W2096287682","https://openalex.org/W2106234246","https://openalex.org/W2111312975","https://openalex.org/W2112757377","https://openalex.org/W2112759697","https://openalex.org/W2114098415","https://openalex.org/W2114438728","https://openalex.org/W2124512686","https://openalex.org/W2125362489","https://openalex.org/W2126275851","https://openalex.org/W2126310082","https://openalex.org/W2127745545","https://openalex.org/W2139008103","https://openalex.org/W2145835533","https://openalex.org/W2147535764","https://openalex.org/W2147775209","https://openalex.org/W2171141282","https://openalex.org/W2209699441","https://openalex.org/W2242155271","https://openalex.org/W2250013128","https://openalex.org/W2332800771","https://openalex.org/W2604406857","https://openalex.org/W2761274815"],"related_works":["https://openalex.org/W2589835102","https://openalex.org/W2171090689","https://openalex.org/W2093084676","https://openalex.org/W2244332036","https://openalex.org/W2230363630","https://openalex.org/W2281506636","https://openalex.org/W2074823829","https://openalex.org/W2132697290","https://openalex.org/W2625150318"],"abstract_inverted_index":{"BACKGROUND:":[0],"Bevacizumab":[1],"and":[2,35,51,73,125,129,141,154,171,183],"irinotecan":[3,107],"may":[4],"represent":[5],"one":[6],"of":[7,86,89,121,156,181,193],"the":[8,152,169,179],"most":[9],"active":[10],"treatments":[11],"in":[12,21,31,158,162],"progressive":[13,44,165],"malignant":[14,45,166],"glioma.":[15,167],"Limited":[16],"published":[17],"experience":[18],"with":[19,23,43,56,101,160,164,178,191],"bevacizumab":[20,57,102,105,110,157,182],"patients":[22,42,78,116,163,194],"CNS":[24,145],"tumors":[25],"raises":[26],"concerns":[27],"regarding":[28],"toxicity,":[29],"particularly":[30],"regards":[32],"to":[33,69,84],"hemorrhage":[34],"thromboembolism.":[36],"METHODS:":[37],"We":[38],"retrospectively":[39],"reviewed":[40],"36":[41],"glioma":[46],"after":[47],"prior":[48,83,198],"resection,":[49],"chemotherapy":[50,161,199],"radiation":[52],"who":[53,79,117],"were":[54,62,91,99,127,173],"treated":[55,100],"at":[58],"our":[59,149],"institution.":[60],"Patients":[61,98],"evaluated":[63],"for":[64,93],"bevacizumab-related":[65],"adverse":[66,94],"events,":[67],"time":[68],"treatment":[70],"failure":[71],"(TTF)":[72],"overall":[74],"survival":[75],"(OS).":[76],"Two":[77],"progressed":[80],"or":[81,109],"died":[82],"completion":[85],"4":[87,138],"cycles":[88,120],"therapy":[90],"analyzed":[92],"events":[95],"only.":[96],"RESULTS:":[97],"alone":[103],"(1),":[104],"plus":[106,111],"(31),":[108],"carboplatin":[112],"(4).":[113],"In":[114],"34":[115],"received":[118,196],">4":[119],"bevacizumab,":[122],"median":[123],"TTF":[124,170],"OS":[126,172],"16":[128],"32":[130],"weeks,":[131],"respectively.":[132],"Toxicities":[133],"included":[134],"1":[135],"arterial":[136],"thrombosis,":[137],"venous":[139],"thromboses,":[140],"3":[142],"clinically":[143],"significant":[144],"hemorrhages.":[146],"CONCLUSION:":[147],"Overall,":[148],"results":[150],"confirm":[151],"efficacy":[153],"safety":[155],"combination":[159,180],"Although":[168],"less":[174],"than":[175],"previously":[176],"reported":[177],"irinotecan,":[184],"this":[185],"was":[186],"an":[187],"unselected":[188],"patient":[189],"population":[190],"50%":[192],"having":[195],">1":[197],"regimen.":[200]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W298939102","counts_by_year":[{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-15T12:55:33.944570","created_date":"2016-06-24T00:00:00"}
